The GNZ-CVD-19 Ab Test is a microfluidic immunofluorescence assay for the qualitative detection of SARS-CoV-2 antibodies in whole human blood or serum to indicate recent or prior infection. The test chip is used with the Genzpro POC device, delivering results in 8-10 minutes, using cloud-based platforms to integrate health system networks and transfer patient data.
Genzpro’s microfluidic chip is designed for single use of serological tests using a finger blood drop specimen that detects the Covid-19 antibodies against Covid-19. Inside of the chip is coated with anti-IgM, IgG antigens that specifically catch human IgG antibodies. The test takes 8-10 minutes in total and gives quantitative results using the GenzPro test device. The test report might be sent to the client or doctor automatically as requested. GenzPro Antibody Rapid test shows the immune response of patients against the Covid-19 virus after 2-14 weeks from the infection in a reliable way.
The GNZ-CVD-19 Ab Test is designed to be used in community care settings to identify individuals with an adaptive immune response to COVID-19, indicating recent or prior infection, antibody therapies, or vaccination.
Easy to implement in point of care settings
Time to result in 10 minutes